MedPath

GRAVERGOL CAPSULES

GRAVERGOL CAPSULES

Discontinued
DIN Number

00116858

Drug Class

Human

Market Date

Dec 31, 1957

Company
HC

can-med pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00116858
AIG Number0302748001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R06AA61 DIMENHYDRINATE, COMBINATIONS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification12:16.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

CAFFEINEActive
Strength: 100 MG
Monograph: CAFFEINE
DIMENHYDRINATEActive
Strength: 50 MG
Monograph: DIMENHYDRINATE
ERGOTAMINE TARTRATEActive
Strength: 1 MG
Monograph: ERGOTAMINE TARTRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.